EPO Patent Application: Anti-c-Met Antibody Drug Conjugates
Summary
The European Patent Office has published a patent application (EP4656248A3) filed by AbbVie Manufacturing Management Unlimited Company for anti-c-Met antibody drug conjugates. The application details compositions and methods for using these conjugates, which are relevant to cancer treatments.
What changed
The European Patent Office (EPO) has published patent application EP4656248A3, filed by AbbVie Manufacturing Management Unlimited Company. This application pertains to anti-c-Met antibody drug conjugates (ADCs), including their compositions and methods of use, which are relevant for therapeutic applications, particularly in oncology.
This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it signifies potential future intellectual property developments in the field of antibody drug conjugates and cancer therapeutics. Companies operating in the pharmaceutical and biotechnology sectors should be aware of this filing as it relates to their research and development landscape.
Source document (simplified)
ANTI-C-MET ANTIBODY DRUG CONJUGATES
Search Report EP4656248A3 Kind: A3 Mar 18, 2026
Applicants
AbbVie Manufacturing Management Unlimited Company
Inventors
PHILLIPS, Andrew C, REILLY, Regina M., DOHERTY, George A., JI, Cheng, BRUNCKO, Milan, BOGHAERT, Erwin R., ANDERSON, Mark
Abstract
The present disclosure provides c-Met antibody drug conjugates (ADCs), including compositions and methods of using such ADCs.
IPC Classifications
C07K 16/28 20060101AFI20260206BHEP A61K 47/68 20170101ALI20260206BHEP C07D 491/22 20060101ALI20260206BHEP C07D 317/44 20060101ALI20260206BHEP C07D 317/70 20060101ALI20260206BHEP A61P 35/00 20060101ALI20260206BHEP C07K 5/062 20060101ALI20260206BHEP C07K 5/09 20060101ALI20260206BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Organic Chemistry (C07D) publishes new changes.